Product Details
Actemra 80 mg**
Tocilizumab80 mg/4 mL
Concentrate for solution for infusion
ROA
Intravenous
Applicant Name
Roche Products Limited
NRN
A6-100068
Status
Active
Composition
Each single-dose vial contains: Tocilizumab 80 mg in 4 mL concentrate (20 mg/mL). Tocilizumab is a humanised IgG1 monoclonal antibody against the human interleukin-6 (IL-6) receptor produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology Excipients with known effects: Each 80 mg vial contains 0.10 mmol (2.21 mg) Sodium
ATC Code
L04AC07
Product Category
Vaccines and Biologics
Marketing Category
Prescription-only Medicine (POM)
Packsize
4 mL x 1’s; 4 mL x 4’s (in vials)
Product Description
Concentrate for solution for IV infusion in single-dose 4-mL vial. A preservative-free, sterile clear, colourless to pale yellow solution
Manufacturer Name
Chugai Pharma Manufacturing Co. Ltd Utsunomiya Plant
Manufacturer Country
JAPAN
Approval Date
2022-12-18
Expiry Date
2027-12-17